Global Laron Syndrome Market, By Treatment (Recombinant Human IGF-I, Mecasermin, Caloric Diet, Others), Diagnosis (Genetic Tests, Hormone Tests, Others), Demographic (Infancy, Neonatal), Symptoms (Short Stature, Reduced Muscle Strength, Hypoglycemia in Infancy, Delayed Puberty, Thin-fragile Hair, Small Genitals, Short Limbs, Dental Abnormalities, Distinctive Facial Features, Obesity, Others), Dosage (Injection, Others), Route of Administration (Subcutaneous, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Laron Syndrome Market
Laron syndrome market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5% in the above mentioned forecast period.
Laron syndrome is a congenital condition defined by short stature, normal or high serum growth hormone (GH), and low blood insulin-like growth factor-1 (IGF-I) levels that do not respond to exogenous GH therapy. This disorder's signs and symptoms are reduced muscle strength, hypoglycemia in infancy, delayed puberty, thin-fragile hair, small genitals, short limbs, dental abnormalities, distinctive facial features, and obesity. Laron syndrome is also known as pituitary dwarfism II, growth hormone insensitivity syndrome, growth hormone receptor deficiency, primary growth hormone insensitivity, primary growth hormone resistance, Laron type pituitary dwarfism I or Laron dwarfism.
The rise in the prevalence of Laron syndrome and rising healthcare expenditure are the major factors influencing the market growth rate. Furthermore, advancement in medical technology, growing government funding and rising initiatives by public and private organizations to spread awareness about the disease and its available treatment options are the factors that will expand the Laron syndrome market.
Rise in the research and development activities and ongoing clinical trials will provide beneficial opportunities for the Laron syndrome market in the forecast period of 2021-2028.
However, lack of cure and high cost associated with the available treatment are the factors that will hinder the market growth. The lack of awareness among the population will further challenge the Laron syndrome market in the aforementioned forecast period.
This Laron syndrome market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Laron syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Laron Syndrome Market Scope and Market Size
The laron syndrome market is segmented on the basis of treatment, diagnosis, demographic, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the laron syndrome market is segmented into recombinant human IGF-I, mecasermin, caloric diet and others.
- On the basis of diagnosis, the laron syndrome market is segmented into genetic tests, hormone tests and others.
- On the basis of demographic, the laron syndrome market is segmented into infancy and neonatal.
- On the basis of symptoms, the laron syndrome market is segmented into short stature, reduced muscle strength, hypoglycemia in infancy, delayed puberty, thin-fragile hair, small genitals, short limbs, dental abnormalities, distinctive facial features, obesity and others.
- On the basis of dosage, the laron syndrome market is segmented into injection and others.
- On the basis of route of administration, the Laron syndrome market is segmented into subcutaneous and others.
- On the basis of end-users, the laron syndrome market is segmented into clinic, hospital and others.
The laron syndrome market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Laron Syndrome Market Country Level Analysis
Laron syndrome market is analyzed and market size information is provided by the country, treatment, diagnosis, demographic, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.
The countries covered in the laron syndrome market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the laron syndrome market due to the presence of major key players, high healthcare expenditure and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities and rising investment in the healthcare sector in this region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Laron syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Laron Syndrome Market Share Analysis
Laron syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Laron syndrome market research.
The major players covered in the Laron syndrome market report are BioVision Inc., Ipsen Pharma, Ipsen Biopharmaceuticals, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-